Sort
50,496 grants matching “lung cancer”
Xenobiotic-Metabolizing Enzymes
$921,928Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Genetic Toxicity Testing Services for the NTP
$921,609Les Recio · Integrated Laboratory Systems, Llc · N01 · FY2015 · ES
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
$921,602Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2020 · CA
An Orbitrap Tribrid mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical School
$921,333Peter Lobel · Rbhs-Robert Wood Johnson Medical School · S10 · FY2019 · OD
Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy
$921,320Katherine Pawelczak · Nerx Biosciences, Inc. · R44 · FY2025 · CA
Studies of Populations Exposed to Occupational Sources of Radiation
$920,982Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Applied Molecular Pathology Laboratory
$920,924Margaret Tucker · Division Of Cancer Epidemiology And Genetics · ZIC · FY2012 · CA
Factors for Epigenetic Silencing of Lung Cancer Genes
$920,685Lovelace Biomedical &Environmental Res · R01 · FY2004 · CA
Radiation-induced translational control of gene expression
$919,974Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Diazeniumdiolates as Broad-Spectrum Anticancer Agents
$919,966Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Validation of a rapid point-of-care breath test for breast cancer
$919,927Michael Phillips · Menssana Research, Inc. · R44 · FY2017 · CA
Regulation of innate lymphocyte function
$919,783Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Vanderbilt Clinical Oncology Research Career Development Award
$919,030Wendy K Rathmell · Vanderbilt University Medical Center · K12 · FY2019 · CA
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
$919,020Lyla Stanland · Enfuego Therapeutics Inc. · R44 · FY2025 · CA
Ligand-Directed KRAS G12V Mutant-Specific Therapeutics
$919,020Lyla Stanland · Enfuego Therapeutics Inc. · R44 · FY2024 · CA
Repurposing of Macrolide Antibiotic Clarithromycin for the Prevention of Lung and Breast Cancer
$918,981Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2019 · CA
Women's Health Study: Continued Follow-Up
$918,834Julie E Buring · Brigham And Women'S Hospital · R01 · FY2009 · HL
Moffitt Imaging Biomarker VAlidation Center
$918,681John J Heine · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2019 · CA
SPECIALIZED CENTER OF RESEARCH IN SCLERODERMA
$918,607University Of Texas Hlth Sci Ctr Houston · P50 · FY2000 · AR
Odorprint Based Disease Diagnostics
$918,295Dmitry Rinberg · New York University School Of Medicine · R01 · FY2024 · DC
NRF Transcription Factors in Environmental Stress and Disease Intervention
$918,204Donna D Zhang · University Of Arizona · R35 · FY2021 · ES
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$917,988Calvin J Kuo · Stanford University · U01 · FY2019 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$917,731Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Clinical Cancer Genomics Program
$917,710Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
Computer Integrated Systems for Microscopy and Manipulation
$917,694Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2014 · EB